BIOLINERX LTD's ticker is BLRX and the CUSIP is 09071M205. A total of 30 filers reported holding BIOLINERX LTD in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,952 | +3.6% | 113,710 | -9.2% | 0.00% | – |
| Q2 2023 | $199,710 | +91.4% | 125,210 | +6.4% | 0.00% | – |
| Q1 2023 | $104,350 | +50.3% | 117,710 | 0.0% | 0.00% | – |
| Q4 2022 | $69,449 | +61.5% | 117,710 | +152.7% | 0.00% | – |
| Q3 2022 | $43,000 | -33.8% | 46,576 | -7.9% | 0.00% | – |
| Q2 2022 | $65,000 | -44.4% | 50,576 | -26.2% | 0.00% | – |
| Q1 2022 | $117,000 | -22.0% | 68,576 | -6.8% | 0.00% | – |
| Q4 2021 | $150,000 | -17.6% | 73,576 | +11.4% | 0.00% | – |
| Q3 2021 | $182,000 | -2.2% | 66,076 | 0.0% | 0.00% | – |
| Q2 2021 | $186,000 | +1.1% | 66,076 | 0.0% | 0.00% | – |
| Q1 2021 | $184,000 | +70.4% | 66,076 | +54.1% | 0.00% | – |
| Q4 2020 | $108,000 | +285.7% | 42,876 | +154.1% | 0.00% | – |
| Q3 2020 | $28,000 | -17.6% | 16,876 | -15.1% | 0.00% | – |
| Q2 2020 | $34,000 | +142.9% | 19,876 | +82.8% | 0.00% | – |
| Q1 2020 | $14,000 | – | 10,876 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 270,665 | $463,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $47,000 | 0.05% |
| Cutter & CO Brokerage, Inc. | 18,667 | $32,000 | 0.01% |
| Opaleye Management Inc. | 16,667 | $29,000 | 0.01% |
| Apollon Wealth Management, LLC | 56,410 | $96,000 | 0.01% |
| Sandy Cove Advisors, LLC | 3,597 | $6,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 104,032 | $178,000 | 0.00% |
| Thomasville National Bank | 10,000 | $17,000 | 0.00% |
| Geneos Wealth Management Inc. | 32,950 | $56,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 9,923 | $17,000 | 0.00% |